Downloaded 23 times
Uploaded byEdgar Hernández
Esc 2011
This document highlights several studies presented at the ESC 2011 conference, including studies on: 1) Apixaban vs. warfarin for atrial fibrillation patients and the 11-year follow up of the ASCOT lipid-lowering trial. 2) The effects and safety of dalcetrapib on vascular function in coronary heart disease patients. 3) The PURE epidemiological study and the effects of eplerenone on heart failure patients. 4) The SHIFT echocardiography substudy on heart rate reduction and left ventricular function. 5) Colchicine for recurrent pericarditis and prolonging dual antiplatelet treatment after stenting. 6)
More Related Content
Esc 2011
- 1. ESC 2011: Highlights Dr.Edgar F. Hernández Paz, M.A.G.C, F.A.C.C.
- 2. ARISTOTLE Apixaban vs. Warfarinin Patients with Atrial Fibrillation Apixaban vs. Warfarin in Patients with Atrial Fibrillation
- 7. ASCOT-11 The Anglo-Scandinavian CardiacOutcomes Trial Lipid Lowering Arm (ASCOT-LLA) 11 Year Mortality Follow-Up in the UK The Anglo-Scandinavian Cardiac Outcomes Trial Lipid Lowering Arm (ASCOT-LLA) 11 Year Mortality Follow-Up in the UK
- 13. dal-VESSEL Vascular Effects andSafety of Dalcetrapib in Patients with or at Risk of Coronary Heart Disease Vascular Effects and Safety of Dalcetrapib in Patients with or at Risk of Coronary Heart Disease
- 17. *FMD: Flow MediatedVasodilation
- 19. PURE The Prospective UrbanRural Epidemiologic Study The Prospective Urban Rural Epidemiologic Study
- 23. EMPHASIS-HF The Effect ofEplerenone vs. Placebo on Cardiovascular Mortality or Heart Failure Hospitalization in Subjects with NYHA Class II Chronic Systolic Heart Failure: An Analysis of the “High Risk Groups” The Effect of Eplerenone vs. Placebo on Cardiovascular Mortality or Heart Failure Hospitalization in Subjects with NYHA Class II Chronic Systolic Heart Failure: An Analysis of the “High Risk Groups”
- 24.
- 29. SHIFT Effect of HeartRate Reduction with Ivabradine on Left Ventricular Volume and Function: Results of the SHIFT Echocardiographic Substudy Effect of Heart Rate Reduction with Ivabradine on Left Ventricular Volume and Function: Results of the SHIFT Echocardiographic Substudy
- 35. CORP Colchicine for RecurrentPericarditis Colchicine for Recurrent Pericarditis
- 39. PRODIGY Prolonging Dual AntiplateletTreatment After Grading Stent-Induced Intimal Hyperplasia Study Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia Study
- 45. EXAMINATION A Clinical Evaluationof Xience-V Stent in Acute Myocardial Infarction A Clinical Evaluation of Xience-V Stent in Acute Myocardial Infarction
- 51. The Italian Elderly-ACSRandomised Trial Early Aggressive vs. Initially Conservative Strategy in Elderly Patients witn non-ST elevation Acute Coronary Syndrome Early Aggressive vs. Initially Conservative Strategy in Elderly Patients witn non-ST elevation Acute Coronary Syndrome
- 58.